Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva

@article{Patsalos2013TherapeuticDM,
  title={Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva},
  author={P. Patsalos and D. Berry},
  journal={Therapeutic Drug Monitoring},
  year={2013},
  volume={35},
  pages={4–29}
}
  • P. Patsalos, D. Berry
  • Published 2013
  • Medicine
  • Therapeutic Drug Monitoring
  • Abstract:Blood (serum/plasma) antiepileptic drug (AED) therapeutic drug monitoring (TDM) has proven to be an invaluable surrogate marker for individualizing and optimizing the drug management of patients with epilepsy. Since 1989, there has been an exponential increase in AEDs with 23 currently licensed for clinical use, and recently, there has been renewed and extensive interest in the use of saliva as an alternative matrix for AED TDM. The advantages of saliva include the fact that for many… CONTINUE READING
    117 Citations
    Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update
    • 78
    • PDF
    Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects
    • 4
    Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva
    • 14
    Dried blood spots for monitoring and individualization of antiepileptic drug treatment.
    • 35

    References

    SHOWING 1-10 OF 280 REFERENCES
    The place of saliva in antiepileptic drug monitoring.
    • 50
    Therapeutic Drug Monitoring of the Newer Antiepileptic Drugs
    • 287
    Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy
    • 35
    Clinical Pharmacokinetics of Levetiracetam
    • 315
    Stability of Salivary Concentrations of the Newer Antiepileptic Drugs in the Postal System
    • 24
    Saliva and Serum Levetiracetam Concentrations in Patients With Epilepsy
    • 23